Idiopathic Sclerochoroidal Calcifications. A Case Report

Abstract

Aim: Sclerochoroidal calcifications (SCHC) are an uncommon benign ocular condition that occurs in elderly patients. SCHC usually manifest as multiple placoid yellow lesions in the midperipheral fundus, most often in the upper temporal quadrant. They are asymptomatic and often discovered during routine eye examinations in a patient with good visual acuity and visual field. According to the etiology, SCHC are divided into idiopathic, metastatic and dystrophic. Case reports: This is case report of 2 patients with idiopathic SCHC, who underwent basic eye examinations, fundus photography, optical coherence tomography, ultrasonography, fluorescein angiography, fundusautofluorescence, laboratory screening and in the second case also CT head scan. Conclusion: The aim of this publication is to point out the typical features of SCHC and their distinction from more serious conditions that they may resemble.

Cytomegalovirus Retinitis Associated With Intravitreal Dexamethasone Implant Injection

“…A literature review through PubMed with various permutations of the search terms “cytomegalovirus retinitis”, “CMV”, “dexamethasone implant”, “dexamethasone”, and “Ozurdex” yielded 8 previously reported cases in the English language, 9 including the patient presented in this report (Table 1). 6,8–15 The average age was 66.9 years, and 6 (66.7%) of the 9 patients were men. The reasons for the initial dexamethasone implant varied and included macular edema caused by CRVO (n = 1), noninfectious panuveitis (n = 3), DM (n = 2), ERM (n = 1), age-related macular degeneration (off-label; n = 1), and a dislocated intraocular lens (n = 1).…”

Diagnosis and Management Strategies in Sclerochoroidal Calcification: A Systematic Review

“…There have been cases in which argon laser photocoagulation (ALPC) was used, 15,17 while lately intravitreal anti-VEGF injections have become the other effective treatment option. 43,47,55,59 However, if CNV is far from the macula, close follow-up of patients with CNV remains as another option. 20,51,57…”